Table 1.
Baseline characteristics of patients without type 2 diabetes (T2D) versus patients with type 2 diabetes
| N | No T2D | T2D |
|---|---|---|
| n = 9005 | n = 1910 | |
| Men, n (%) | 5912 (66) | 1329 (70) |
| Age, years; mean (SD) | 56 (12) | 60 (10) |
| BMI, kg/m2; mean (SD) | 26.5 (4.1) | 29.0 (5.0) |
| Smoking current, n (%) | 3885 (43) | 946 (50) |
| Pack‐years, median (IQR) | 11 (0‐28) | 13 (0‐31) |
| Alcohol use, n (%) | 809 (9) | 272 (14) |
| Systolic blood pressure, mmHg; mean (SD) | 141 (22) | 145 (21) |
| Diastolic blood pressure, mmHg; mean (SD) | 83 (13) | 83 (12) |
| Duration of diabetes, years; median (IQR) | ‐ | 4 (1‐10) |
| Medication | ||
| Glucose‐lowering, n (%) | ‐ | 1262 (66) |
| Insulin, n (%) | ‐ | 455 (24) |
| Lipid‐lowering, n (%) | 4906 (55) | 1218 (64) |
| Blood pressure‐lowering, n (%) | 5927 (66) | 1473 (77) |
| Type of vascular disease | ||
| Coronary artery disease, n (%) | 3684 (41) | 842 (44) |
| Cerebrovascular disease, n (%) | 1857 (21) | 364 (19) |
| Peripheral artery disease, n (%) | 1114 (12) | 269 (14) |
| Abdominal aortic aneurysm, n (%) | 552 (6) | 92 (5) |
| Laboratory measurements | ||
| Glucose, mmol/L; mean (SD) | 5.7 (0.7) | 8.7 (2.9) |
| HbA1c, %; mean (SD) | 5.6 (0.4) | 7.1 (1.3) |
| Triglyceride glucose index; mean (SD) | 8.8 (0.6) | 9.4 (0.7) |
| eGFR, ml/min/1.73 m2; mean (SD) | 78.5 (18.1) | 78.5 (22.1) |
| Micro‐albuminuria, n (%) | 463 (9) | 417 (23) |
| Total cholesterol, mmol/L; mean (SD) | 5.2 (1.4) | 4.8 (1.4) |
| LDL‐c, mmol/L; mean (SD) | 3.2 (1.2) | 2.7 (1.1) |
| HDL‐c, mmol/L; mean (SD) | 1.3 (0.4) | 1.1 (0.3) |
| Non‐HDL‐c, mmol/L; mean (SD) | 3.9 (1.4) | 3.7 (1.4) |
| Triglycerides, mmol/L; median (IQR) | 1.4 (1.0‐2.0) | 1.7 (1.2‐2.5) |
Note: Continuous variables are depicted as mean ± SD, count variables as n (%) and non‐normally distributed variables as median (interquartile range).
Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate.